Immunomodulation With SA-FasL Protein as an Effective Means of Preventing Islet Allograft Rejection in Chemically Diabetic NOD Mice von Yolcu, E.S, Zhao, H, Shirwan, H

Volltext

Mouse T Cells Engineered to Display on Their Surface a Novel Form of FasL Protein Undergo Apoptosis When Stimulated With Alloantigens: Implications for Graft-Versus-Host Disease von Yolcu, E.S, Singh, N.P

Volltext

Posttransplantation Systemic Immunomodulation with SA-FasL–Engineered Donor Splenocytes Has Robust Efficacy in Preventing Cardiac Allograft Rejection in Mice von Zhao, H, Woodward, K.B, Shirwan, H, Grimany-Nuno, O, Yolcu, E.S

Volltext

Engineering of Bone Marrow Cells With Fas-ligand Protein–Enhances Donor-specific Tolerance to Solid Organs von Askenasy, E.M, Shushlav, Y, Sun, Z, Shirwan, H, Yolcu, E.S, Askenasy, N

Volltext

RETRACTED: Characterization of Human CD8+TCR− Facilitating Cells In Vitro and In Vivo in a NOD/SCID/IL2rγnull Mouse Model von Huang, Y., Elliott, M.J., Yolcu, E.S., Miller, T.O., Ratajczak, J., Bozulic, L.D., Wen, Y., Xu, H., Ratajczak, M.Z., Ildstad, S.T.

Volltext

Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapy von Sharma, R K, Yolcu, E S, Elpek, K G, Shirwan, H

Volltext